"Extracellular Vesicles for ‘Liquid Biopsy’ Development in Cancer" by Dr. Karla Williams

The Williams Lab is using nanoscale flow cytometry to identify tumor-derived extracellular vesicles and to profile their protein and glycan composition. Learn how this work has led to the development of a blood-based ‘liquid biopsy’ to risk-stratifying patients, allowing them to distinguish indolent from aggressive disease.